Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0067 | 0.4187 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0052 | 0.2906 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.6925 | 1 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0052 | 0.2906 | 0.4196 |
Trypanosoma brucei | Metacaspase-4 | 0.0052 | 0.2906 | 0.5 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0067 | 0.4187 | 0.3378 |
Trypanosoma cruzi | metacaspase, putative | 0.0052 | 0.2906 | 0.5 |
Plasmodium falciparum | metacaspase 1 | 0.0052 | 0.2906 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0031 | 0.1221 | 0.1764 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0052 | 0.2906 | 0.5 |
Echinococcus granulosus | caspase 8 | 0.0052 | 0.2906 | 0.1919 |
Echinococcus granulosus | caspase 2 | 0.01 | 0.6925 | 0.6497 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0052 | 0.2906 | 0.5 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0067 | 0.4187 | 0.5 |
Plasmodium falciparum | metacaspase-like protein | 0.0052 | 0.2906 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.2906 | 0.4196 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0067 | 0.4187 | 0.3378 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.01 | 0.6925 | 0.6497 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0067 | 0.4187 | 0.5 |
Trypanosoma brucei | metacaspase 5, putative | 0.0052 | 0.2906 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0031 | 0.1221 | 0.1764 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.261 | 0.1581 |
Echinococcus multilocularis | caspase | 0.0136 | 1 | 1 |
Echinococcus granulosus | caspase | 0.0136 | 1 | 1 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.01 | 0.6925 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0052 | 0.2906 | 0.5 |
Trypanosoma brucei | metacaspase MCA2 | 0.0052 | 0.2906 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0052 | 0.2906 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0052 | 0.2906 | 0.5 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.0136 | 1 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0052 | 0.2906 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.1173 | 0.1694 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0052 | 0.2906 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.261 | 0.3769 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0052 | 0.2906 | 0.5 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.0136 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0052 | 0.2906 | 0.5 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0052 | 0.2906 | 0.5 |
Plasmodium vivax | metacaspase 1, putative | 0.0052 | 0.2906 | 0.5 |
Trypanosoma brucei | metacaspase | 0.0052 | 0.2906 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0052 | 0.2906 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0052 | 0.2906 | 0.5 |
Trypanosoma cruzi | metacaspase, putative | 0.0052 | 0.2906 | 0.5 |
Echinococcus multilocularis | caspase 3 | 0.0085 | 0.5685 | 0.5084 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0052 | 0.2906 | 0.5 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0067 | 0.4187 | 0.3378 |
Brugia malayi | intermediate filament protein | 0.0031 | 0.1221 | 0.1764 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0052 | 0.2906 | 0.5 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0052 | 0.2906 | 0.5 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0052 | 0.2906 | 0.5 |
Onchocerca volvulus | 0.0048 | 0.261 | 0.2434 | |
Echinococcus multilocularis | apoptotic protease activating factor 1 | 0.0048 | 0.261 | 0.1581 |
Brugia malayi | hypothetical protein | 0.0048 | 0.261 | 0.3769 |
Echinococcus granulosus | caspase 3 | 0.0085 | 0.5685 | 0.5084 |
Brugia malayi | Cell death protein 3 precursor | 0.01 | 0.6925 | 1 |
Echinococcus multilocularis | caspase 8 | 0.0052 | 0.2906 | 0.1919 |
Trypanosoma cruzi | metacaspase, putative | 0.0052 | 0.2906 | 0.5 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0062 | 0.381 | 0.5502 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0067 | 0.4187 | 0.5 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0052 | 0.2906 | 0.1919 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.1221 | 0.1764 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0052 | 0.2906 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0136 | 1 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0052 | 0.2906 | 0.5 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0052 | 0.2906 | 0.5 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0067 | 0.4187 | 0.6046 |
Trypanosoma cruzi | metacaspase, putative | 0.0052 | 0.2906 | 0.5 |
Trypanosoma brucei | metacaspase MCA3 | 0.0052 | 0.2906 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0052 | 0.2906 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0031 | 0.1221 | 0.1764 |
Echinococcus multilocularis | caspase 2 | 0.01 | 0.6925 | 0.6497 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.0048 | 0.261 | 0.1581 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.